应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
00853 微创医疗
交易中 08-13 11:44:16
7.130
-0.080
-1.11%
最高
7.345
最低
7.020
成交量
1,004万
今开
7.110
昨收
7.210
日振幅
4.51%
总市值
136.68亿
流通市值
136.68亿
总股本
19.17亿
成交额
7,170万
换手率
0.52%
流通股本
19.17亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）
资讯
新帖
简况
微创医疗上半年持续经营业务同比增长12%-14%，净亏损不超5000万美元
投资观察 · 08-12 23:39
微创医疗上半年持续经营业务同比增长12%-14%，净亏损不超5000万美元
微创医疗预计2026年上半年持续经营净亏损不超过5000万美元
美股速递 · 08-12 22:25
微创医疗预计2026年上半年持续经营净亏损不超过5000万美元
微创医疗（00853）发布2026年中期业绩预告：持续经营收入同比增12%至14%
公告速递 · 08-12 22:20
微创医疗（00853）发布2026年中期业绩预告：持续经营收入同比增12%至14%
微创医疗发布7月股份变动月报表，股本结构保持稳定
公告速递 · 08-05
微创医疗发布7月股份变动月报表，股本结构保持稳定
微创医疗：拟向天智航出售上海微创骨科62%股权 发行价每股14.36元
格隆汇 · 07-29
微创医疗：拟向天智航出售上海微创骨科62%股权 发行价每股14.36元
微创医疗拟向天智航出售62%上海微创骨科股权 对价以A股股份支付
公告速递 · 07-29
微创医疗拟向天智航出售62%上海微创骨科股权 对价以A股股份支付
2.5秒消融、体内放疗！进博百天倒计时，企业亮出微创医疗硬核黑科技
上观新闻 · 07-24
2.5秒消融、体内放疗！进博百天倒计时，企业亮出微创医疗硬核黑科技
微创医疗变卖骨科业务，业绩对赌和债务压力下持续甩卖资产
消费日报财经 · 07-23
微创医疗变卖骨科业务，业绩对赌和债务压力下持续甩卖资产
国内首套智能体互联国标推进落地，美团、滴滴、联想等参与试点
凤凰网科技 · 07-22
国内首套智能体互联国标推进落地，美团、滴滴、联想等参与试点
异动解读｜微创医疗盘中上涨5.11%，出售骨科业务引发市场分歧后股价修复
行情直击 · 07-20
异动解读｜微创医疗盘中上涨5.11%，出售骨科业务引发市场分歧后股价修复
异动解读｜微创医疗盘中下跌6.74%，出售骨科业务引发市场分歧加剧
行情直击 · 07-17
异动解读｜微创医疗盘中下跌6.74%，出售骨科业务引发市场分歧加剧
【券商聚焦】中信建投：建议关注Q2医疗设备高增长公司配置机会
金吾财讯 · 07-17
【券商聚焦】中信建投：建议关注Q2医疗设备高增长公司配置机会
港股异动 | 微创医疗(00853.HK)涨超6% 天智航拟收购上海微创骨科医疗控股权益 加速布局海外骨科一体化市场
智通财经 · 07-16
港股异动 | 微创医疗(00853.HK)涨超6% 天智航拟收购上海微创骨科医疗控股权益 加速布局海外骨科一体化市场
重大资产重组！天智航拟购买上海骨科控股权，7月16日起停牌
北京商报 · 07-15
重大资产重组！天智航拟购买上海骨科控股权，7月16日起停牌
微创医疗：天智航医疗技术以发行新股方式支付对价
美股速递 · 07-15
微创医疗：天智航医疗技术以发行新股方式支付对价
微创医疗(00853)：天智航(688277.SH)拟收购上海微创骨科医疗控股权益
智通财经 · 07-15
微创医疗(00853)：天智航(688277.SH)拟收购上海微创骨科医疗控股权益
微创医疗子公司等签署意向书 拟处置上海微创骨科控股权
美股速递 · 07-15
微创医疗子公司等签署意向书 拟处置上海微创骨科控股权
微创医疗（00853）披露海外骨科业务潜在股权转让事宜
公告速递 · 07-15
微创医疗（00853）披露海外骨科业务潜在股权转让事宜
微创医疗(00853.HK)遭摩根大通减持598.77万股
中金财经 · 07-09
微创医疗(00853.HK)遭摩根大通减持598.77万股
小摩减持微创医疗(00853.HK)约74.56万股 每股作价6.7024港元
智通财经 · 07-09
小摩减持微创医疗(00853.HK)约74.56万股 每股作价6.7024港元
加载更多
公司概况
公司名称：
微创医疗
所属市场：
SEHK
上市日期：
--
主营业务：
微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大动脉及外周血管介入业务分部包括“L-REBOA”主动脉阻断球囊等产品。神经介入业务分部包括脑动脉粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。
发行价格：
--
{"stockData":{"symbol":"00853","market":"HK","secType":"STK","nameCN":"微创医疗","latestPrice":7.13,"timestamp":1786592650783,"preClose":7.21,"halted":0,"volume":10044700,"delay":0,"changeRate":-0.011095700416088776,"floatShares":1917000000,"shares":1917000000,"eps":-1.0074941341724672,"marketStatus":"交易中","change":-0.08,"latestTime":"08-13 11:44:16","open":7.11,"high":7.345,"low":7.02,"amount":71697763,"amplitude":0.045076,"askPrice":7.135,"askSize":5600,"bidPrice":7.125,"bidSize":10400,"shortable":3,"etf":0,"ttmEps":1.5459103999748889,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786593600000},"marketStatusCode":2,"adr":0,"listingDate":1285257600000,"exchange":"SEHK","adjPreClose":7.21,"openAndCloseTimeList":[[1786584600000,1786593600000],[1786597200000,1786608000000]],"volumeRatio":1.674449,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00853","defaultTab":"news","newsList":[{"id":"1130484506","title":"微创医疗上半年持续经营业务同比增长12%-14%，净亏损不超5000万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130484506","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1130484506?lang=zh_cn&edition=full","pubTime":"2026-08-12 23:39","pubTimestamp":1786549187,"startTime":"0","endTime":"0","summary":"微创医疗科学有限公司近日发布业绩预告，为其上半年经营表现画出了清晰轮廓。公司预计，截至2026年6月30日的六个月里，其持续经营业务将实现同比12%至14%的营收增长。这一增速，无疑为市场注入了一剂强心针。整体来看，微创医疗正在经历一场深刻的转型与调整。随着下半年行业旺季的到来，公司能否延续这一积极势头，成为市场关注的焦点。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","BK1589","BK1585","BK1583","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143012372","title":"微创医疗预计2026年上半年持续经营净亏损不超过5000万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143012372","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143012372?lang=zh_cn&edition=full","pubTime":"2026-08-12 22:25","pubTimestamp":1786544730,"startTime":"0","endTime":"0","summary":"微创医疗（00853.HK）最新披露，预计截至2026年6月30日的六个月期间，来自持续经营业务的净亏损将不超过5000万美元。这一预期数据，透露出公司在该阶段经营上面临的压力，同时也为市场划定了明确的亏损上限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","BK1100","BK1589","BK1583","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114112412","title":"微创医疗（00853）发布2026年中期业绩预告：持续经营收入同比增12%至14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114112412","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114112412?lang=zh_cn&edition=full","pubTime":"2026-08-12 22:20","pubTimestamp":1786544442,"startTime":"0","endTime":"0","summary":"微创医疗科学有限公司8月12日公布截至2026年6月30日止六个月的中期业绩预告。受约43百万美元财务成本，以及汇率波动、可转换贷款公允价值重估及部分资产减值等一次性与非现金因素影响，预计持续经营业务期内净亏损不超过50百万美元，上年同期净亏损为49百万美元。公司计划在2026年8月末前发布正式的中期业绩公告，并提醒投资者在买卖公司证券时保持审慎。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a3893e2538b44a4c9453f52433cb6ed2","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131181763","title":"微创医疗发布7月股份变动月报表，股本结构保持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1131181763","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1131181763?lang=zh_cn&edition=full","pubTime":"2026-08-05 16:47","pubTimestamp":1785919641,"startTime":"0","endTime":"0","summary":"微创医疗科学有限公司于2026年8月5日发布了截至2026年7月31日的股份变动月报表。公告显示，公司法定股本维持在5,000,000,000股普通股，面值为0.00001美元，合计法定股本5万美元，与上月保持一致。公司声明已遵守香港联交所《上市规则》及相关法律法规的要求，并确认截至2026年7月31日，公司股本总数维持不变。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655089366","title":"微创医疗：拟向天智航出售上海微创骨科62%股权 发行价每股14.36元","url":"https://stock-news.laohu8.com/highlight/detail?id=2655089366","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655089366?lang=zh_cn&edition=full","pubTime":"2026-07-29 21:02","pubTimestamp":1785330147,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1589","BK1100","00853","BK1583","BK1585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1153564521","title":"微创医疗拟向天智航出售62%上海微创骨科股权 对价以A股股份支付","url":"https://stock-news.laohu8.com/highlight/detail?id=1153564521","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1153564521?lang=zh_cn&edition=full","pubTime":"2026-07-29 20:40","pubTimestamp":1785328848,"startTime":"0","endTime":"0","summary":"2026年7月29日，微创医疗科学有限公司公告，旗下苏州微创骨科科学（集团）有限公司与其他股东已于2026年7月29日与北京天智航医疗科技股份有限公司签署《发行股份购买资产协议》，就向天智航转让上海微创骨科医疗科技有限公司62%股权达成条件性协议。根据协议，苏州微创拟转让其持有的目标公司约44.29%股权，其他股东合计转让约17.71%股权；天智航将以每股人民币14.36元向各转让方发行A股股份作为对价。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653081395","title":"2.5秒消融、体内放疗！进博百天倒计时，企业亮出微创医疗硬核黑科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2653081395","media":"上观新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653081395?lang=zh_cn&edition=full","pubTime":"2026-07-24 19:08","pubTimestamp":1784891330,"startTime":"0","endTime":"0","summary":"一根纤细的导管穿过血管抵达心脏，一组电极进入大脑深部，一枚枚肉眼几乎难以分辨的微球沿着供血动脉进入肿瘤。器械越来越精细，医生能够到达的部位越来越深入，许多过去需要开胸、开腹完成的治疗，如今可以通过一个微小切口进行。第九届中国国际进口博览会进入百天倒计时。波士顿科学也展示了包括房颤综合治疗、AI辅助冠脉介入、肿瘤精准内放射治疗和脑深部神经刺激等多个前沿医疗“黑科技”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607243820631230.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607243820631230.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1585","BK1100","00853","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653728419","title":"微创医疗变卖骨科业务，业绩对赌和债务压力下持续甩卖资产","url":"https://stock-news.laohu8.com/highlight/detail?id=2653728419","media":"消费日报财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653728419?lang=zh_cn&edition=full","pubTime":"2026-07-23 20:51","pubTimestamp":1784811060,"startTime":"0","endTime":"0","summary":"消费日报讯微创医疗科学有限公司（简称“微创医疗”）又一次变卖了核心资产。日前，A股上市公司天智航发布公告，拟以发行股份方式收购上海微创骨科医疗科技有限公司（简称“上海微创骨科”）控股权，交易预计构成重大资产重组。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607233819191757.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607233819191757.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["00853","BK1100","BK1583","BK1585","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653555781","title":"国内首套智能体互联国标推进落地，美团、滴滴、联想等参与试点","url":"https://stock-news.laohu8.com/highlight/detail?id=2653555781","media":"凤凰网科技","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653555781?lang=zh_cn&edition=full","pubTime":"2026-07-22 07:15","pubTimestamp":1784675756,"startTime":"0","endTime":"0","summary":"凤凰网科技讯 7月22日，据中关村科学城消息，《人工智能 智能体互联》系列国家标准应用推进专题会议日前在北京召开。据介绍，《人工智能 智能体互联》系列标准包括智能体身份码、跨域发现、协同交互、工具调用等七项标准，覆盖智能体身份认证、发现连接、交互协作和工具使用等环节，旨在解决不同厂商智能体之间兼容性不足、身份可信机制缺失以及跨域协作受限等问题。根据会上公布的信息，AIP相关方案已在多个行业场景进行验证。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8uxVtwdE3UE","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["LU1023057109.AUD","HK0000306701.USD","LU0140636845.USD","LU0348788117.USD","LU0708995583.HKD","LU2778985437.USD","DIDIY","LU0449515922.USD","LU1366334651.USD","LU1868837722.USD","LU0359202008.SGD","IE00BPRC5H50.USD","LU0348827113.USD","LU0577902538.SGD","LU0791590937.USD","TCHI","LU0572944931.SGD","LU0048580855.USD","LU0054237671.USD","LU0605514214.HKD","SG9999002828.SGD","LU0196878994.USD","BK1610","LU0634319403.HKD","LU0181495838.USD","LU0880133367.SGD","IE00B031HY20.USD","LU1235295612.USD","BK1521","LU0054450605.USD","80992","LU2097828631.EUR","LU0345775950.USD","LU0228659784.USD","LU0501845795.SGD","LU0819123356.HKD","BK1618","LU1267930227.SGD","LU0541501648.USD","LU0052756011.USD","LU0315178854.USD","SG9999014674.SGD","LU2097828557.USD","LU0531971595.HKD","LU0588545904.SGD","LU0417516902.SGD","IE00B3M56506.USD","LU0823039010.USD","LU0348814723.USD","LU0314109678.HKD","LU1808992512.USD","LU0117841782.USD","LU0128525689.USD","LU0828238088.HKD","LU0862451753.SGD","LU2226246903.HKD","LU0633140727.USD","LU2097828714.EUR","LU1366334578.USD","LU0873338254.USD","LU0307460666.USD","LU0261950983.USD","LU1868838027.USD","LU2039709279.SGD","BK1583","LU0211977185.USD","LU0264606111.USD","LU0287142896.SGD","LU0650527681.SGD","03690","LU1719994722.HKD","LU0572939691.SGD","LU0164865239.USD","LU1720050803.USD","LU0918141887.USD","BK1193","LU2148510915.USD","LU0251144936.SGD","LU0862451837.USD","LU2488822045.USD","LU0918141705.HKD","IE0008368742.USD","LNVGY","LU1734074674.USD","LU0029875118.USD","LU0359201885.HKD","LU1105468828.SGD","HK0000320264.USD","LU0828237510.HKD","LU1188198961.HKD","LU1993786604.SGD","LU2242644610.SGD","LU1064131003.USD","LU1226287529.USD","LU2045819591.USD","LU0348825331.USD","LU1868837565.USD","LU0541502299.USD","LU2125910500.SGD","LU0128522157.USD","LU1242518931.SGD","LU1481107354.HKD","HK0000306685.HKD","IE0032431581.USD","LU1961090484.USD","HMTD.SI","LU0672654166.SGD","LU0231483743.USD","BK1575","LU0072462343.USD","LU0326950275.SGD","LU0214875030.USD","IE00B0JY6N72.USD","BK4230","LU0431992006.USD","LU0823038988.USD","LU0823426480.USD","LU0828237940.HKD","LU1048596156.SGD","00853","LU1770036033.HKD","IE00B543WZ88.USD","IE0034224299.USD","LU0210526637.USD","LU0819121731.USD","LU0823041008.USD","LU1048588211.SGD","LU0149721374.USD","SG9999000327.SGD","LU0572940350.SGD","LU0106252389.USD","LU0456846285.SGD","00992","LU0821914370.USD","LU0499858438.USD","LU0165289439.USD","SG9999001903.USD","IE0008369823.USD","LU0588545730.USD","LU0878005551.USD","LU1064130708.USD","LU2476274720.SGD","SG9999001689.USD","LU0499858602.USD","LU2257852520.SGD","LU0173614495.USD","LU0540923850.HKD","LU0047713382.USD","LU0052750758.USD","LU0594300419.USD","BK1607","KWEB","LU0594300179.USD","LU1046422090.SGD","BK1142","LU1880383366.USD","LU0463099449.HKD","LU1960683339.HKD","SG9999002562.SGD","LU0543330483.HKD","LU0143863198.USD","LU1224709979.USD","LU1251922891.USD","LU0823040885.USD","LU1102505762.USD","LU0633140560.USD","LU0589944569.HKD","LU0979878070.USD","LU0164872284.USD","BK1591","LU0049853897.USD","LU1152091754.HKD","LU0359201612.USD","LU0797268264.HKD","LU0043850808.USD","LU0067412154.USD","LU0320764755.SGD","LU1102505929.USD","LU0417516738.SGD","LU1831875114.USD","LU1303224171.USD","LU0345776255.USD","LU2152927971.USD","LU1328277881.USD","LU0049112450.USD","BK1615","IE00B29SXG58.USD","LU2097828805.USD","SG9999000459.SGD","LU0164880469.USD","LU1688375341.USD","LU1807302812.USD","LU1880383440.USD","LU0310800965.SGD","LU0072913022.USD","BK4022","LU1242518857.USD","IE00B5MMRT66.SGD","SG9999002463.SGD","LU0593848301.USD","LU1008478684.HKD","LU0449509016.USD","BK1604","LU0683595622.HKD","LU1675838814.USD","BK1233","BK1526","LU0588545490.SGD","LU0348805143.USD","LU0577902298.EUR","IE00BF5LJ272.USD","LU0455707207.USD","LU0456827905.SGD","LU0577902454.USD","LU0051755006.USD","LU0561508036.HKD","LU0700851271.USD","LU0856984785.SGD","LU1328615791.USD","LU0084288322.USD","LU0327786744.USD","LU2087589342.USD","LU0039217434.USD","LU0244354667.USD","BK1585","LU0269904917.USD","LU0370786039.SGD","LU1323998911.USD","BK1100","METmain","LU0132412106.USD","LU0588546209.SGD","LU0865486749.SGD","LU0868486357.SGD","LU1794554557.SGD","LU0502904849.HKD","LU0509642566.USD","LU0577902371.SGD","LU0348735423.USD","LU0823426308.USD","LU2097828474.EUR","LU1152091168.USD","MPNGY","LU0871576103.HKD","LU1770034418.SGD","LU0791591158.USD","LU1282648689.USD","LU0577902611.USD","LU1813983027.USD","BK1589","LU0737861699.HKD","LU0011963245.USD","HK0000320223.HKD","LU0326948709.USD","LU0348816934.USD","LU2476274308.USD","LU0048597586.USD","LU0320764599.SGD","LU0143863784.USD","LU0890818403.SGD","LU0611395673.USD","LU2399975544.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173559762","title":"异动解读｜微创医疗盘中上涨5.11%，出售骨科业务引发市场分歧后股价修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1173559762","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1173559762?lang=zh_cn&edition=full","pubTime":"2026-07-20 15:06","pubTimestamp":1784531183,"startTime":"0","endTime":"0","summary":"7月20日，微创医疗盘中上涨5.11%，报7.0港元，成交额9925.51万港元。消息面上，公司7月15日公告旗下苏州微创骨科拟向天智航出售上海微创骨科82.29%股权，对价以天智航发行新股方式支付。此前该消息公布后市场分歧加剧，股价于7月17日大跌逾6%。当前反弹或反映市场对剥离亏损板块、聚焦核心业务逻辑的重新认可。上海微创骨科主营美日欧髋膝关节重建业务，代表产品内轴膝全球累计植入超100万例，但该业务近年持续承压，剥离后有望改善集团利润率。交易仍处筹划阶段，存在不确定性。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122317060","title":"异动解读｜微创医疗盘中下跌6.74%，出售骨科业务引发市场分歧加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1122317060","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1122317060?lang=zh_cn&edition=full","pubTime":"2026-07-17 14:02","pubTimestamp":1784268154,"startTime":"0","endTime":"0","summary":"7月17日，微创医疗盘中下跌6.74%，报6.64港元，成交额1.17亿港元。消息面上，公司7月15日公告旗下苏州微创骨科与天智航签署意向书，拟出售上海微创骨科82.29%股权，对价以天智航发行新股方式支付。市场在初期利好消化后分歧加剧：一方面，出售核心海外资产或反映公司偿债压力及半年报业绩承压；另一方面，天智航作为尚未盈利的科创板企业，其换股对价的实际变现能力存在不确定性。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"微创医疗出售骨科业务引发市场分歧加剧","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652785473","title":"【券商聚焦】中信建投：建议关注Q2医疗设备高增长公司配置机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2652785473","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652785473?lang=zh_cn&edition=full","pubTime":"2026-07-17 08:56","pubTimestamp":1784249774,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，板块26Q1业绩整体承压。医疗设备预计Q2招标偏弱，部分企业新品及海外驱动增长；医疗器械上游部分公司收入有望高增长；高值耗材受医疗合规要求提升影响，部分企业预计增长良好；IVD低基数下增速有望改善；家用器械部分企业有望延续高增长；医疗服务边际有所回暖。建议关注Q2高增长公司的配置机会，建议关注国产替代向中高端延伸，看好出海、新科技（AI、脑机接口）及并购整合等新技术落地。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986094","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00241","BK1591","LU0173614495.USD","BK1247","02235","BK1515","BK1600","BK1571","06826","BK1615","09996","01066","BK1583","BK0276","BK1100","02190","159873","BK1584","BK1161","LU0287142896.SGD","BK1617","BK1189","01302","BK1574","BK1610","BK1585","BK1587","BK1501","KCE","BK1502","BK1593","00853","HK0000165453.HKD","02252","BK1222","601066","BK1589","BK1142"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651418372","title":"港股异动 | 微创医疗(00853.HK)涨超6% 天智航拟收购上海微创骨科医疗控股权益 加速布局海外骨科一体化市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2651418372","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651418372?lang=zh_cn&edition=full","pubTime":"2026-07-16 11:31","pubTimestamp":1784172677,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00853","BK1585","BK1583","BK1100","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651652469","title":"重大资产重组！天智航拟购买上海骨科控股权，7月16日起停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2651652469","media":"北京商报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651652469?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:58","pubTimestamp":1784123927,"startTime":"0","endTime":"0","summary":"北京商报讯（记者董亮王悦彤）7月15日晚间，天智航（688277）披露公告称，公司正在筹划以发行股份的方式购买上海微创骨科医疗科技有限公司（以下简称“上海骨科”）的控股权，同时拟募集配套资金（以下简称“本次交易”）。公司股票将于7月16日开市起停牌，预计停牌时间不超过5个交易日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607153807768683.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607153807768683.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1100","00853","BK1583","BK1585","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161781920","title":"微创医疗：天智航医疗技术以发行新股方式支付对价","url":"https://stock-news.laohu8.com/highlight/detail?id=1161781920","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1161781920?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:34","pubTimestamp":1784122464,"startTime":"0","endTime":"0","summary":"微创医疗科学公司宣布，相关交易对价将通过天智航医疗技术公司发行新股的方式完成支付。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1585","BK1100","00853","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651465248","title":"微创医疗(00853)：天智航(688277.SH)拟收购上海微创骨科医疗控股权益","url":"https://stock-news.laohu8.com/highlight/detail?id=2651465248","media":"智通财经","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651465248?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:03","pubTimestamp":1784120630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，微创医疗 公布，于2026年7月15日，公司附属公司苏州微创骨科学(集团)有限公司与北京天智航医疗科技股份有限公司(天智航)订立意向书，内容有关天智航可能向苏州微创及上海微创骨科医疗科技有限公司其他股东收购目标公司的控股权益，代价将以天智航发行新股的方式支付。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1468109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1589","00853","BK1585","BK0251","BK1583","159891","688277"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196454725","title":"微创医疗子公司等签署意向书 拟处置上海微创骨科控股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1196454725","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196454725?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:03","pubTimestamp":1784120605,"startTime":"0","endTime":"0","summary":"微创医疗旗下子公司及其他相关方，已就处置其所持有的上海微创骨科有限公司控股权事宜，签署了一份意向书。此举标志着相关方在调整资产组合与优化业务结构方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853","BK1100","BK1589","BK1585","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185510759","title":"微创医疗（00853）披露海外骨科业务潜在股权转让事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1185510759","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185510759?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:01","pubTimestamp":1784120465,"startTime":"0","endTime":"0","summary":"微创医疗7月15日公告称，其附属公司苏州微创骨科科学（集团）有限公司已与北京天智航医疗科技股份有限公司签署意向书，探讨向天智航及目标公司其他股东出售上海微创骨科医疗科技有限公司控股权。交易对价拟以天智航发行新股的方式支付。根据公告，截至意向书签署日，苏州微创持有目标公司82.29%股权，目标公司被纳入微创医疗合并报表范围，负责集团国际（非中国）骨科业务，在美国、日本和欧洲等市场从事髋关节及膝关节重建业务。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650897559","title":"微创医疗(00853.HK)遭摩根大通减持598.77万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650897559","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650897559?lang=zh_cn&edition=full","pubTime":"2026-07-09 23:57","pubTimestamp":1783612625,"startTime":"0","endTime":"0","summary":"格隆汇2月7日丨根据联交所最新权益披露资料显示，2025年2月3日，微创医疗(00853.HK)遭JPMorgan Chase & Co.以每股均价6.3936港元减持好仓598.77万股，涉资约3828.33万港元。\r\n\r\n 减持后，JPMorgan Chase & Co.最新持好仓数目为160,998,898股，持好仓比例由9.04%下降至8.71%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202607/09/20260709895357.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202607/09/20260709895357.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260709/32303536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU1116320737.USD","BK1589","IE00BHPRN162.USD","IE00BN8TJ469.HKD","BK4585","IE00B3S45H60.SGD","IXG","JPX","FNCL","BK4534","LU0251132253.USD","LU1261432733.SGD","LU2023250330.USD","LU1116320901.HKD","LU1145028129.USD","JPO","LU2242649171.HKD","IYF","LU0211331839.USD","LU2054465674.USD","UYG","LU0964807845.USD","BK4207","IYG","IE00BJTD4V19.USD","LU1084165304.USD","LU0820561818.USD","IE0034235303.USD","LU2505996509.AUD","IE00BJLML261.HKD","LU2237443895.HKD","LU0683600562.USD","IE00B1BXHZ80.USD","LU1551013342.USD","LU2237443622.USD","FTXO","LU0868494617.USD","JPMO","BK4566","KBWB","PGF","LU2264538146.SGD","LU1267930490.SGD","LU1629891620.HKD","XLF","LU1720051017.SGD","LU0149725797.USD","VFH","LU1162221912.USD","00853"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292500","title":"小摩减持微创医疗(00853.HK)约74.56万股 每股作价6.7024港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292500","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650292500?lang=zh_cn&edition=full","pubTime":"2026-07-09 18:59","pubTimestamp":1783594783,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00853","BK1585","BK1583","BK1100","BK1589"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.microport.com.cn","stockEarnings":[{"period":"1week","weight":0.0595},{"period":"1month","weight":0.0826},{"period":"3month","weight":-0.0999},{"period":"6month","weight":-0.3614},{"period":"1year","weight":-0.4462},{"period":"ytd","weight":-0.3336}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0507},{"period":"3month","weight":-0.036},{"period":"6month","weight":-0.0424},{"period":"1year","weight":0.0188},{"period":"ytd","weight":-0.0074}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"微创医疗科学有限公司是一家主要从事医疗器械的销售、生产、研究及开发（R&D）的投资控股公司。该公司通过八个分部开展业务。心血管介入业务分部包括植入器械、通路器械等产品。骨科医疗器械业务分部包括关节重建、脊柱等器械。心律管理（CRM）业务分部包括起搏器、除颤器等器械。大动脉及外周血管介入业务分部包括“L-REBOA”主动脉阻断球囊等产品。神经介入业务分部包括脑动脉粥样硬化狭窄、弹簧圈等产品。结构性心脏病业务分部包括经导管主动脉瓣植入术等产品。手术机器人业务分部从事手术机器人器械的制造及研发。外科医疗器械业务分部从事外科医疗器械的制造及研发。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.009025},{"month":2,"riseRate":0.4375,"avgChangeRate":0.009312},{"month":3,"riseRate":0.5,"avgChangeRate":0.015172},{"month":4,"riseRate":0.375,"avgChangeRate":0.012111},{"month":5,"riseRate":0.5625,"avgChangeRate":0.020952},{"month":6,"riseRate":0.4375,"avgChangeRate":0.033969},{"month":7,"riseRate":0.5625,"avgChangeRate":0.033502},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.047547},{"month":9,"riseRate":0.6,"avgChangeRate":0.032463},{"month":10,"riseRate":0.625,"avgChangeRate":0.009684},{"month":11,"riseRate":0.4375,"avgChangeRate":0.005167},{"month":12,"riseRate":0.375,"avgChangeRate":-0.015138}],"exchange":"SEHK","name":"微创医疗","nameEN":"MICROPORT"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"微创医疗,00853,微创医疗股票,微创医疗股票老虎,微创医疗股票老虎国际,微创医疗行情,微创医疗股票行情,微创医疗股价,微创医疗股市,微创医疗股票价格,微创医疗股票交易,微创医疗股票购买,微创医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"微创医疗(00853)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供微创医疗(00853)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}